Etiotropic activity of the combined drug «EshriPhage» in vitro

The intensification of the production of livestock and poultry products determines the strengthening of biological control and containment of the morbidity of animals, including birds, as well as the spread of infections that determine sanitary and epizootic distress. Coli-salmonella infection is widespread. By their antibiotic resistance, the microorganisms Escherichia coli and Salmonella spp. they belong to a high and critical priority group, most of the existing antibiotics for which are not active. To implement the tasks facing veterinary science and practice, formed by the global problem of combating epizootics of escherichiosis and salmonellosis, ensuring sanitary well-being, including products, a drug based on bacteriophages «EshriPhage» has been developed. Commission tests of the etiotropic activity of the combined agent «EshriPhage» in vitro in the spot test revealed a high level of epizootically significant isolates of coli-salmonella infection. Data are presented that allow us to recommend the widespread introduction of EshriPhage into practice and the further development of methods of epizootic control over bacterioses using bacteriophages.